Get answers for your health queries from top Doctors for FREE!

100% Privacy Protection

100% Privacy Protection

We maintain your privacy and data confidentiality.

Verified Doctors

Verified Doctors

All Doctors go through a stringent verification process.

Quick Response

Quick Response

All Doctors go through a stringent verification process.

Reduce Clinic Visits

Reduce Clinic Visits

Save your time and money from the hassle of visits.

Ask Free Question

  1. Home >
  2. Blogs >
  3. Breast Cancer Metastasis to the Liver
  • Cancer
  • Breast Cancer

Breast Cancer Metastasis to the Liver

By Shreya Sanas| Last Updated at: 22nd Mar '24| 16 Min Read

Overview

Breast cancer metastasis to the liver occurs when cancer cells break away from the primary tumor in the breast and travel through the bloodstream or lymphatic system to the liver. The prognosis when breast cancer spreads to the liver and bones varies greatly depending on the individual's overall health, the extent of the spread, and the effectiveness of treatment.

Breast cancer metastasis to the liver is where cancer cells from the breast reach the liver and form a new tumor. This condition is a very serious complication of breast cancer as it spreads from its original site and spreads to another part of your body.

Free vector cancer development process infographic

The liver is a common site for metastasis of cancer because it is an important organ filtering the blood. It is also located close to the stomach and intestines which are common sites of cancer. Breast cancer metastasis to the liver can lead to further complications and lead to a transplant.

The rate of metastasis can be higher in certain groups, like people with triple-negative breast cancer or people that are in advanced stages of cancer. Also, the rate of metastasis can also depend on the type of treatment you receive before and after the diagnosis.

Do you know India is a preferred destination for liver transplants? Which provides the best treatment at an affordable cost.

Let’s find out how common breast cancer metastasis is in the liver!

How common is it for breast cancer to metastasize to the liver?

Generally, breast cancer spreads to other organs in the body, like the lungs, bones or even the brain before it reaches the liver. It is very uncommon for breast cancer to metastasize to the liver. 

Approximately 50% of people diagnosed with metastatic breast cancer (meaning the cancer has spread beyond the breasts) develop liver metastases.

While less common, liver metastases can also occur in earlier stages of breast cancer. One study estimated that 1.4% of breast cancer patients at initial diagnosis already have liver involvement.

But, breast cancer can spread to the liver, and as cancer progresses, the risk of metastasis increases which can further cause more severe ailments like cirrhosis, liver transplant, etc.


Free photo 3d medical background with virus cells and dna strand

The chances of breast cancer that has metastasized to the liver also depend on various factors like the stage and type of cancer. People with triple-negative breast cancer have more risks that their cancer will spread to other organs than others. Also, the more advanced the cancer is (for example, if it has spread to the lymph nodes), it is more likely to spread to other organs.

You must be wondering, how does breast cancer actually spread to the liver?

Your health is too important to ignore – schedule your appointment now.

How does breast cancer spread to the liver?

Cancer cells can spread through your bloodstream or lymphatic system throughout your whole body. Cancer cells can travel to other parts of the body and form new tumors when they enter the bloodstream or lymphatic system.


Free vector diagram showing process of cancer development

When it comes to breast cancer, the cancer cells can spread to the liver and form a new tumor. This can happen when the cancer is spread beyond the breast and lymph nodes because the cancer cells can possibly enter the bloodstream or lymphatic system at this point. 

Not all breast cancer tumors travel to the liver or other organs. Many types of breast cancer are treatable with surgery, chemotherapy, radiation therapy, or a combination of these methods. 

How do you know if breast cancer has spread to the liver?

Free vector human liver structure. organ human, medical science, health internal

There are several ways through which doctors might decide if breast cancer has spread to the liver:

  • Physical Examination: While doing a physical examination, your doctor might feel your abdomen to check for any changes like lumps. They might also check for changes in your skin or the whites of your eyes. These could sometimes be signs of liver cancer.
  • Blood tests: To check for high levels of specific substances present in the liver, your doctor might order a blood test. These substances can include certain proteins, enzymes, and substances that can cause tumors.
  • Imaging tests: CT scans or MRIs can get a detailed view of your liver. Your doctor may order these tests to check for tumors.
  • Biopsy: A small sample of tissue might be taken from the liver and examined under a microscope. This can detect cancer cells. This process is called biopsy and it is used to confirm if breast cancer is spread to the liver.

Take the first step to recovery. Get in touch with us for your treatment. 

 

At what stage does breast cancer spread to the liver?

Breast cancer can spread to the liver or any other organs at any stage. The risk of liver metastasis is slightly higher for certain types of aggressive breast cancers, like triple-negative and HER2-positive, even in early stages.

Though, as cancer progresses, the risk of metastasis increases.

Breast cancer is generally divided into 4 stages. It can depend on:

  • Size of the tumor
  • The extent to which the cancer is spread to the lymph nodes
  • If the cancer is spread to other organs.

Let’s see what treatments are available for breast cancer metastasis to the liver!

Breast Cancer Metastasis to Liver Treatment

Free vector tiny cartoon doctors examining liver of patient. hepatitis treatment, cancer awareness flat vector illustration. disease, health, care concept for banner, website design or landing web page

Breast cancer metastasis to liver treatment depends on the type and the stage of the cancer. 

Some common treatments for breast cancer that has spread to the liver include:

  • Surgery: If the cancer is limited to a small area of the liver, it might be possible to remove it surgically. A portion of the liver can be removed. This process is called hepatectomy. 
    Ablation Therapy: Ablation uses hot or cold to destroy cancer cells. This can be done using different techniques like radiofrequency ablation, microwave ablation, and cryoablation.
  • Embolization: The embolization procedure blocks the blood, oxygen, and nutrient supply to the cancer cells that are present in the liver. This causes cancer cells to die. This process can be done using techniques like chemotherapy embolization and radioembolization.
  • Chemotherapy: This treatment uses drugs to kill the cancer cells or at least stop them from dividing. Chemotherapy can be given through a vein or orally (in pill form).
  • Targeted Therapy: This treatment uses drugs that target only cancer cells, without affecting normal cells. Targeted therapy can be given orally or through the veins.
  • Radiation Therapy: This therapy uses high-energy beams for killing cancer cells or stopping them from dividing. 

Breast Cancer Metastasis to Liver Survival Rate

Free photo close-up hands holding purple ribbon with stethoscope

Breast cancer metastasis to liver survival rate depends on several factors:

  • the type and stage of the breast cancer
  • the size and number of liver tumors
  • the patient's overall health.

According to Dr. Danielle Leonardo, an Oncologist at My Breast Cancer Team
“Breast cancer with liver metastasis have a poorer prognosis compared to patients who have bone-only metastasis. The survival rate will range from 3 to 12 months for untreated disease. The goal for these patients will be to give palliative systemic therapy in the hopes of shrinking the liver masses and further delaying liver failure. It is also important that the patient be co-managed by GI/hepatologists to watch out for signs of impending liver failure and to give supportive treatment.”

Generally, the survival rate for breast cancer metastasis is less than the survival rate of breast cancer not spreading to other organs. 

The American Cancer Society reports that the five-year survival rate for breast cancer that has not spread to other areas of the body is approximately 98%. Breast cancer that has spread to other regions of the body has a five-year survival rate of roughly 27%.

It is important to know that survival rates can be different depending on the specific conditions of each person. Some people with breast cancer metastasis to the liver may live longer than others.

New Research Going On For Breast Cancer Metastasis to the Liver

In the realm of breast cancer metastasis to the liver, recent advancements in treatment approaches are pivotal.

  • Targeted Therapies: We're seeing a surge in research focusing on drugs that precisely target molecules involved in liver metastasis. HER2-targeted therapies, particularly for HER2-positive breast cancer, are a prime example. They represent a significant shift towards more tailored and effective treatment strategies.
  • Immunotherapy: This approach is revolutionizing cancer treatment. By harnessing the body's immune system, particularly through checkpoint inhibitors and CAR-T cell therapy, there's a new frontier in attacking cancer cells within the liver.
  • Combination Therapies: Combining different treatment modalities, like chemotherapy with targeted therapies or immunotherapy, is a strategy gaining traction. This approach aims to amplify treatment efficacy and tackle drug resistance.
  • Personalized Medicine: The future of cancer treatment lies in personalization. Treatments are increasingly being tailored based on individual tumor characteristics and the specific risk profile for liver metastasis.
  • In the realm of emerging therapies:
  • Nanomedicine: The development of nanoparticles for targeted drug delivery to liver metastases holds great promise. This approach could minimize side effects while maximizing treatment effectiveness.
  • Radiotherapy: Innovations in targeted radiotherapy aim to treat liver metastases with minimal impact on healthy liver tissue.
  • Surgical Interventions: Advances in surgical techniques, including minimally invasive methods, are enhancing the treatment of liver metastases. Personalized surgical plans are becoming more prevalent, offering a more patient-specific approach to surgery.

These developments in treating breast cancer metastasis to the liver reflect a broader shift towards more precise, effective, and patient-centric cancer care.

FAQs 

FAQ colorful typography banner

What is breast cancer metastasis to the liver?

Answer: Breast cancer metastasis to the liver is the spread of breast cancer cells to the liver, where they form new tumors.

What are the symptoms of breast cancer metastasis to the liver?

Answer: Symptoms may include abdominal pain, jaundice, nausea, fatigue, and weight loss.

How is breast cancer metastasis to the liver diagnosed?

Answer: Diagnosis typically involves imaging tests such as CT scans, MRIs, and PET scans, as well as liver function tests and biopsies.

What are the treatment options for breast cancer metastasis to the liver?

Answer: Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

How long can someone live with breast cancer metastasis to the liver?

Answer: Survival rates vary depending on factors such as the stage of cancer, overall health, and treatment options.

What are the risk factors for breast cancer metastasis to the liver?

Answer: Risk factors include advanced-stage breast cancer, larger tumor size, hormone receptor-negative cancer, and lymph node involvement.

Can breast cancer metastasis to the liver be prevented?

Answer: There is no guaranteed way to prevent metastasis, but early detection and treatment of breast cancer may reduce the risk.

What is the outlook for someone with breast cancer metastasis to the liver?

Answer: The outlook varies depending on factors such as the stage of cancer, overall health, and treatment options, but the prognosis is generally poorer than for breast cancer that has not spread.
 

Your well-being is our priority - call us to book your appointment today

References:

https://www.breastcancer.org/ 

https://www.medicalnewstoday.com/

https://www.ncbi.nlm.nih.gov/pmc/

Related Blogs

Question and Answers

. Heterogeneous Soft Tissue Nodule in the Right Lower Lobe (RLL) Size: 14 x 8 mm This nodule is described as heterogeneously enhancing, which suggests it may have varying levels of blood flow or different tissue densities within it. This could be indicative of a tumor. 2. Air Space Opacification in the Right Upper Lobe (RUL) Finding: There is patchy air space opacification with interlobular septal thickening in the posterior segment of RUL. This could represent infection, inflammation, or more concerningly, metastatic disease or lung cancer causing these changes. 3. Left-sided Pleural Effusion and Subsegmental Atelectasis Pleural Effusion: Mild left-sided pleural effusion is noted. Pleural effusion can occur in the context of metastatic disease or cancer. Atelectasis: This refers to partial lung collapse, which may occur when there is a mass obstructing the airflow or due to pleural fluid. 4. Enlarged Mediastinal and Hilar Lymph Nodes Lymphadenopathy: There are multiple enlarged and necrotic lymph nodes, most notably in the right hilar region, with the largest measuring 35 x 25 mm. Enlargement and necrosis of lymph nodes can be a sign of metastatic spread. The presence of enlarged lymph nodes in the mediastinum and hilum is typical of malignancy spreading beyond the primary lung site. 5. Liver Lesion Size: 14 x 13 mm lesion in the right hepatic lobe, which is well-defined and peripherally enhancing. A hypodense lesion could indicate a metastatic tumor, especially since it shows peripheral enhancement, a characteristic of some types of metastases. 6. Skeletal Lesions Multiple Lesions: There are mixed lytic and sclerotic bony lesions, some with soft tissue components. These lesions involve the vertebrae, ribs, glenoids, sternum, sacral ala, iliac bones, and femur. Soft Tissue Components: Some of the lesions, such as those in the ribs and iliac bones, have a soft tissue component, which suggests more advanced involvement, possibly indicating metastases. 7. Other Findings: No signs of emphysema, bronchiectasis, or pneumothorax were noted, which is reassuring as it reduces the likelihood of certain types of lung diseases. The liver, spleen, pancreas, kidneys, urinary bladder, and prostate all appear normal on imaging, which helps to rule out major issues in these organs. Impression: The findings of a heterogeneously enhancing solitary pulmonary nodule in the right lung, with associated hilar and mediastinal lymphadenopathy, along with a hepatic lesion and extensive skeletal involvement (with mixed lytic and sclerotic lesions), strongly raise concern for metastatic disease, most likely originating from the lung. The primary lung cancer is a potential consideration, though other primary sites are also possible. Next Steps: Histopathological correlation: This means a biopsy or tissue sample should be taken from one of the lesions (pulmonary, hepatic, or bone) to confirm whether the lesions are malignant and, if so, to identify the type of cancer. This will help determine the best course of treatment. The overall picture suggests a metastatic malignancy, likely of pulmonary origin, but further investigations and biopsy are essential to establish a definitive diagnosis and treatment plan.

Male | 58

Answered on 8th Mar '25

Read answer

Cancer Hospitals In Other Cities

Top Related Speciality Doctors In Other Cities

Cost Of Related Treatments In Country

Consult